NewsRoom Articles - Page 58 of 220

MondayDec 11, 2023 11:15 am

SOHM Inc. (SHMN) Taps into UACI’s Robust Resources and Specialized Infrastructure for ABBIE Advancement

SOHM, a generic drug manufacturing and distributing innovator, announced its development collaboration with the University of Arizona Center for Innovation (“UACI”) for the advancement of its ABBIE platform In the arrangement, SOHM will establish offices and a wet lab bench, taking advantage of UACI’s robust and specialized infrastructure SOHM’s management is optimistic about the collaboration and is confident that this is but the first step toward deepening new lab operations It also marks a significant milestone, as it anticipates monetizing ABBIE off-the-shelf, non-viral gene editing kits SOHM (OTC: SHMN), a generic drug manufacturing and distributing innovator, just announced its development…

MondayDec 11, 2023 9:45 am

Stem Cell Therapy Shows Promise in Halting Progression of Cognitive Decline in MS Patients

A team of researchers from Italy’s Hospital Casa Solleivo della Sofferenza, the University of Milan Bicocca and the University of Cambridge have discovered that stem cell therapy may be effective at slowing the progression of cognitive decline in patients with multiple sclerosis (MS). MS is a debilitating neurological disorder that occurs when the immune system becomes dysfunctional and begins attacking the protective covering around nerve fibers. There are four types of MS, with two of them being progressive. That means their symptoms become more and more severe over time, causing the patient’s disability to worsen as the disease progresses. Around…

MondayDec 11, 2023 9:00 am

Astrotech Corp. (NASDAQ: ASTC) Is ‘One to Watch’

In November 2023, the company announced a purchase order from a Romanian company for seven TRACER 1000 ETDs to be deployed in a European airport Astrotech announced in June 2023 that its board unanimously rejected an unsolicited acquisition proposal from BML Investment Partners In May 2023, the company announced a purchase order from a Romanian company for 17 TRACER 1000 ETDs, to be delivered during calendar 2023 Astrotech confirmed test results from field trials of the AgLAB 1000-D2 mass spectrometer for hemp and cannabis producers, improving yields by an average of 24% In December 2022, the company effected a 1-for-30…

FridayDec 08, 2023 3:06 pm

Many Fellowship Programs for Infectious Disease Specialists Remain Unfilled in US

Many infectious disease specialist fellowship programs across the country remain unfulfilled with only 74% of ID fellowship positions and 56% of ID fellowship programs being filled on Match Day. The Infectious Diseases Society of America (IDSA) notes that the overall number of infectious disease applicants has reduced despite a further increase in certified program numbers. IDSA president and vice chair of Cleveland Clinic’s Department of Infectious Diseases Steven K. Schmitt, MD, FIDSA, explains that there is a persisting shortage of ID physicians in both pediatric and adult ID. Data from the society shows that only 74% of 441 ID fellowship…

FridayDec 08, 2023 9:00 am

The 2023 Nobel Prize in Chemistry’s Spotlight on Nanotechnology Shines Light on Clene Inc. (NASDAQ: CLNN) Efforts to Develop Catalytically Active Nanoparticles

The 2023 Nobel Prize in Chemistry, awarded to Moungi G. Bawendi, Louis E. Brus, and Aleksey Yekimov for their efforts in discovering and synthesizing quantum dots, recognizes the power of nanotechnology Nanoscience is the study of structures and molecules whose sizes range between 1 and 100 nm, while nanotechnology is the technology that utilizes nanoscience in practical applications The applications of nanotechnology are wide-ranging, from industrial-scale catalysis and modern electronics to precision medicine and quantum technology Clene Inc., a late clinical-stage biopharmaceutical company, has applied nanotechnology alongside other science concepts in the development of catalytically active nanocrystals The catalytic activities…

ThursdayDec 07, 2023 2:27 pm

Researchers Harnessing Immune System to Fight Cancer More Effectively

Researchers from several institutions are working to harness the immune system’s ability to fight diseases to combat cancer more effectively. The immune system is critical to defending the body from outside invaders, such as harmful microorganisms that can cause lethal infections. According to University of Oxford Kidani professor of immuno-oncology Tim Elliot, the immune system also plays a critical role in fighting cancer by spotting and destroying rogue cells before they can snowball into full-blown cancer. Scientists have begun leveraging their understanding of the interactions between the immune system and cancer cells to come up with innovative cancer-treatment strategies. These…

WednesdayDec 06, 2023 2:29 pm

Four Niches e-Commerce Startups Can Leverage

Every startup jumping into the e-commerce segment will have to leverage every trick in the book to succeed. The segment is fiercely competitive and is home to thousands upon thousands of companies fighting for a market share, including giants such as Amazon and Google that have essentially monopolized their respective markets. E-commerce took center stage during the coronavirus pandemic when global lockdowns forced hundreds of millions of people worldwide to shelter indoors and rely on the internet to secure their needs. People are now more accustomed to shopping online and often prefer it due to the convenience and wide product…

WednesdayDec 06, 2023 10:30 am

PaxMedica Inc. (NASDAQ: PXMD) Completes Key Type-B FDA Meeting, Discussing Positive Results from PAX-HAT-301 Study

During the live type-B meeting, PaxMedica discussed the positive results of the recent data from its PAX-HAT-301 study of suramin in Stage One HAT, also called African Sleeping Sickness The FDA is allowing PaxMedica to use previous data from early tests of suramin to begin developing the drug for use in current cases of HAT PaxMedica received constructive feedback, which will aid in completing the remaining work necessary to file a New Drug Application (“NDA”), expected in the second half of 2024 The global ASD therapeutics market was valued at $1.93 billion in 2022 and is expected to reach $3.42…

TuesdayDec 05, 2023 3:31 pm

Already-Approved Treatments Could Be Tested in Fight Against Brain Metastasis

A recent review of research papers on brain cancers that have metastasized to the lungs has discovered that already-approved treatments could be clinically tested as potential therapies against brain metastasis. The University of Bristol study also discovered genetic differences between smokers and nonsmokers. Brain cancer metastasis affects roughly 25,000 patients in the United Kingdom, with the cancers typically originating from the lungs or breasts and causing death in most of this patient class. Although substantial research efforts have been dedicated toward understanding primary lung cancer genetic mutation, much less is known about the cancer’s genetic environment once it spreads to…

TuesdayDec 05, 2023 9:00 am

PaxMedica Inc. (NASDAQ: PXMD) Closes Public Offering of Approximately $7 Million and Continues Pursuing ASD Pipeline

PaxMedica’s total gross proceeds from the offering, before deducting the placement agent’s fees and other offering expenses, were approximately $7 million The company intends to use the proceeds to pay an outstanding promissory note, advance development programs, and general corporate purposes PaxMedica received constructive feedback from its type-B meeting with the FDA, which will aid in completing the remaining paperwork necessary to file a New Drug Application The company is currently working on commercial lots of PAX-101, which are expected during the first half of 2024, for the New Drug Application, which is expected to be filed during the second…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

SOHM Inc. (SHMN) Taps into UACI’s Robust Resources and Specialized Infrastructure for ABBIE Advancement

Stem Cell Therapy Shows Promise in Halting Progression of Cognitive Decline in MS Patients

Astrotech Corp. (NASDAQ: ASTC) Is ‘One to Watch’

Many Fellowship Programs for Infectious Disease Specialists Remain Unfilled in US

The 2023 Nobel Prize in Chemistry’s Spotlight on Nanotechnology Shines Light on Clene Inc. (NASDAQ: CLNN) Efforts to Develop Catalytically Active Nanoparticles

Researchers Harnessing Immune System to Fight Cancer More Effectively

Four Niches e-Commerce Startups Can Leverage

PaxMedica Inc. (NASDAQ: PXMD) Completes Key Type-B FDA Meeting, Discussing Positive Results from PAX-HAT-301 Study

Already-Approved Treatments Could Be Tested in Fight Against Brain Metastasis

PaxMedica Inc. (NASDAQ: PXMD) Closes Public Offering of Approximately $7 Million and Continues Pursuing ASD Pipeline

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search